|
AZD7762
Theoretical analysis:AZD7762
MF: C17H19FN4O2S.ClH
MW: 398.888
CAS: 860352-01-8
Availability and price:AZD7762More>>
|
|
|
AT-7519
Theoretical analysis:AT-7519
MF:C16H17Cl2N5O2.HCl
MW:418.71
Solubility: Soluble in DMSO at 10 mM
purity:>98%
CAS...
More>>
|
|
|
ABT-751
Description of:ABT-751
ABT-751 is a bioavailable antimitotic sulfonamide agent that binds to the colchicine-binding site on beta-tubulin and in...
More>>
|
|
|
Flavopiridol(Alvocidib)
Description of:Flavopiridol(Alvocidib)
Flavopiridol (at 7.5 mg/kg) significantly inhibited the growth of xenografted rhabdoid tumors, and its e...
More>>
|
|
|
Flavopiridol hydrochloride
Description of:Flavopiridol hydrochloride
Flavopiridol (at 7.5 mg/kg) significantly inhibited the growth of xenografted rhabdoid tumors, and it...
More>>
|
|
|
SNS-032(BMS387032)
Description of:SNS-032(BMS387032)
SNS-032 (formerly BMS-387032) is a small-molecule cyclin-dependent kinase (CDK) inhibitor currently in phase ...
More>>
|
|
|
AZD-5438
Description of:AZD-5438
AZD-5438 is a potent inhibitor of cyclin-dependent kinase (cdk) 1, 2 and 9 (IC50 values are 16, 6 and 20 nM respectivel...
More>>
|
|
|
R547
Description of:R547
In vivo, R547 showed antitumor activity. The selective kinase inhibition profile and the preclinical antitumor activity of ...
More>>
|
|
|
PHA-848125
Description of:PHA-848125
PHA-848125 can have a therapeutic potential in melanoma patients, alone or combined with TMZ. Moreover this agent app...
More>>
|
|
|
Dinaciclib(Sch 727965)
Description of:Dinaciclib(Sch 727965)
SCH 727965 inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nmol/...
More>>
|
|